Both in Pharmaceuticals
Verastem vs ArriVent BioPharma
Over the past year VSTM returned −6.6% and AVBP returned −18.7%; their daily moves had a correlation of 0.19.
VSTM −6.6% AVBP −18.7%Growth of $1, one year, split-adjusted
| Metric | VSTM | AVBP |
|---|---|---|
| Price | $8.78 | $16.73 |
| Market cap | $794.7M | $824.7M |
| Today | −4.93% | −0.39% |
| 1 month | +16.2% | −41.0% |
| 6 months | +33.4% | −43.6% |
| Year to date | +13.7% | −16.9% |
| 1 year | −6.6% | −18.7% |
| Revenue growth (YoY) | +1775.4% | — |
| Gross margin | 89.9% | — |
| Net margin | −86.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.1× | — |
| Net cash | $54.6M | $373.1M |
| Dividend yield | — | — |
| Volatility (60d) | 71.3% | 137.5% |
| Short % of float | 17.7% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).